These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15622330)

  • 1. More on abacavir-induced neuropsychiatric reactions.
    Foster R; Taylor C; Everall IP
    AIDS; 2004 Dec; 18(18):2449. PubMed ID: 15622330
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient.
    Soler Palacin P; Aramburo A; Moraga FA; Cabañas MJ; Figueras C
    Pediatr Infect Dis J; 2006 Apr; 25(4):382. PubMed ID: 16568000
    [No Abstract]   [Full Text] [Related]  

  • 3. Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome.
    Ahmad M
    J Postgrad Med; 2006; 52(4):296-7. PubMed ID: 17102551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients.
    Bellagamba R; Tommasi C; De Marco M; Narciso P
    J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915
    [No Abstract]   [Full Text] [Related]  

  • 5. Large lymphadenopathies complicating the abacavir hypersensitivity reaction.
    García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS
    AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersensitivity reactions due to abacavir.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
    Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S
    Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice?
    Barber TJ; Marett B; Waldron S; Portsmouth S; Mackie NE; Weston R; Winston A
    AIDS; 2007 Aug; 21(13):1823-4. PubMed ID: 17690585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute respiratory manifestations of the abacavir hypersensitivity reaction.
    Herring SJ; Krieger AC
    AIDS; 2006 Jan; 20(2):301-2. PubMed ID: 16511430
    [No Abstract]   [Full Text] [Related]  

  • 10. Vertigo and abacavir.
    Fantry LE; Staecker H
    AIDS Patient Care STDS; 2002 Jan; 16(1):5-7. PubMed ID: 11839213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal lactic acidosis associated with tenofovir and abacavir.
    Giola M; Basilico C; Grossi P
    Int J Infect Dis; 2005 Jul; 9(4):228-9. PubMed ID: 15916912
    [No Abstract]   [Full Text] [Related]  

  • 12. Abacavir hypersensitivity reaction.
    AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observational study with abacavir. Decreased viral load and quality of life improves].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():52-3. PubMed ID: 11373782
    [No Abstract]   [Full Text] [Related]  

  • 14. Abacavir-induced liver toxicity in an HIV-infected patient.
    Di Filippo E; Ripamonti D; Rizzi M
    AIDS; 2014 Feb; 28(4):613. PubMed ID: 24469001
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziagen (abacavir) approved: caution essential.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe metabolic acidosis and Fanconi syndrome during stavudine and abacavir therapy in a resource-limited setting.
    Bansie RD; Vreden SG
    Braz J Infect Dis; 2012; 16(6):610-1. PubMed ID: 23141987
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart attack risk with abacavir and didanosine.
    AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
    [No Abstract]   [Full Text] [Related]  

  • 18. Sweet's syndrome following abacavir therapy.
    Del Giudice P; Vandenbos F; Perrin C; Bernard E; Marq L; Dellamonica P
    J Am Acad Dermatol; 2004 Sep; 51(3):474-5. PubMed ID: 15337997
    [No Abstract]   [Full Text] [Related]  

  • 19. 1592 (abacavir): do not rechallenge after hypersensitivity reaction.
    James JS
    AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring abacavir bioactivation in humans: screening for an aldehyde metabolite.
    Grilo NM; Antunes AM; Caixas U; Marinho AT; Charneira C; Conceição Oliveira M; Monteiro EC; Matilde Marques M; Pereira SA
    Toxicol Lett; 2013 May; 219(1):59-64. PubMed ID: 23467017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.